Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure

NCT06144918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: SBI-100 Ophthalmic Emulsion, 0.5%
DRUG: SBI-100 Ophthalmic Emulsion, 1.0%
DRUG: SBI-100 Ophthalmic Emulsion, Placebo

Sponsor

Skye Bioscience, Inc.